France's Orange to exit New York Stock Exchange-March 2024-www.financetom.com

France's Orange to exit New York Stock Exchange

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

France's Orange to exit New York Stock Exchange

Sep 24, 2024 11:13 PM

Sept 25 (Reuters) - French telecom operator Orange

announced on Wednesday its intention to delist its

shares from the New York Stock Exchange (NYSE), citing the

financial cost of this secondary listing.

"This decision is expected to have no impact on Orange's

clients and partners or its commercial presence in U.S.," the

group said.

Previous page： Eupraxia Pharmaceuticals Q4 Loss Widens Next page： Karman Amends Credit Agreement to Raise Revolving Commitments by $100 Million

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Eupraxia Pharmaceuticals Q4 Loss Widens

Mar 13, 2026

07:19 AM EDT, 03/13/2026 (MT Newswires) -- Eupraxia Pharmaceuticals ( EPRX ) overnight Thursday reported a wider fourth-quarter net loss. The company incurred a net loss of US$16.7 million, compared with a net loss of US$7.5 million for the prior year period. The company did not provide per share amounts. The wider net loss was due to higher research and...

Karman Amends Credit Agreement to Raise Revolving Commitments by $100 Million

Mar 13, 2026

07:23 AM EDT, 03/13/2026 (MT Newswires) -- Karman Holdings ( KRMN ) said Friday it amended its credit agreement to increase the revolving credit commitments by $100 million to a total of $150 million. The amendment also removed the cap on incremental revolving credit commitments, which was previously $50 million, the company said in a regulatory filing. ...

GSK Says US FDA Expands Arexvy Vaccine Approval to At-Risk Adults Under 50

Mar 13, 2026

07:23 AM EDT, 03/13/2026 (MT Newswires) -- GSK (GSK) said Friday the US Food and Drug Administration has expanded the approved indication of its Arexvy vaccine to include adults 18 to 49 years old who are at increased risk of lower respiratory tract disease caused by respiratory syncytial virus, or RSV. The company said the expanded approval was supported by...

Joby Aviation Completes Piloted Electric Air Taxi Demonstration Flights Across San Francisco Bay Area

Mar 13, 2026

07:25 AM EDT, 03/13/2026 (MT Newswires) -- Joby Aviation ( JOBY ) said Friday that it has completed a series of piloted electric air taxi demonstration flights across the San Francisco Bay Area to show its operational readiness to scale its presence across the US. Moreover, the company said it was selected as a partner in multiple winning applications under...